NUCLEOLAR ORGANIZER REGIONS (AGNORS) AS PREDICTORS IN TRANSITIONAL CELL BLADDER-CANCER

被引:47
作者
LIPPONEN, PK
ESKELINEN, MJ
NORDLING, S
机构
[1] UNIV KUOPIO,DEPT SURG,SF-70210 KUOPIO,FINLAND
[2] UNIV KUOPIO,DEPT PATHOL,KUOPIO,FINLAND
[3] UNIV HELSINKI,DEPT PATHOL,SF-00100 HELSINKI 10,FINLAND
关键词
D O I
10.1038/bjc.1991.478
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The predictive value of silver stained nucleolar organiser regions (AgNORs) was assessed in 229 patients with transitional cell bladder cancer followed up for over 10 years. The AgNORs were enumerated in pretreatment biopsy specimens. The AgNORs were related to clinical stage (T)(P = 0.0111), papillarity (P < 0.0001), WHO grade (P < 0.0001), DNA ploidy (P = 0.0010) and S-phase fraction (P < 0.0001). Tumours presenting with pelvic lymph node involvement (P = 0.0085) or metastasis (P = 0.0780) at the time of diagnosis had more AgNORs than tumours confined to the bladder wall. Progression in T-, N- and M-categories (P = 0.0010-0.0030) was related to AgNORs and consequently they predicted bladder cancer related survival (P = 0.0005). The diploid tumours could be regrouped according to survival by AgNORs (P = 0.0001). In papillary tumours AgNORs predicted progression (P = 0.0110) and survival (P = 0.0038). In Ta-T1 tumours AgNORs predicted progression (P = 0.11) and survival (P = 0.0751) and also in T2-T3 tumours AgNORs contributed to survival significantly (P = 0.0039). The AgNORs subdivided WHO grade III tumours according to their ability to progress during the follow-up time (P = 0.0711). In a multivariate analysis AgNORs predicted progression independently in Ta-T1 category (P = 0.0165). AgNORs predicted recurrence free period like SPF (P = 0.0010). In conclusion, AgNORs are inferior to classic prognostic factors or DNA flow cytometric variables in muscle invasive bladder cancers whereas they have independent predictive value in superficial cancers.
引用
收藏
页码:1139 / 1144
页数:6
相关论文
共 27 条
  • [1] THE VALUE OF MORPHOMETRY AND DNA FLOW-CYTOMETRY IN ADDITION TO CLASSIC PROGNOSTICATORS IN SUPERFICIAL URINARY-BLADDER CARCINOMA
    BLOMJOUS, ECM
    SCHIPPER, NW
    BAAK, JPA
    VOS, W
    DEVOOGT, HJ
    MEIJER, CJLM
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 91 (03) : 243 - 248
  • [2] CAIRNS P, 1989, ARCH PATHOL LAB MED, V113, P1250
  • [3] HOW SHOULD WE COUNT AGNORS - PROPOSALS FOR A STANDARDIZED APPROACH
    CROCKER, J
    BOLDY, DAR
    EGAN, MJ
    [J]. JOURNAL OF PATHOLOGY, 1989, 158 (03) : 185 - 188
  • [4] NUCLEOLAR ORGANIZER REGIONS AND PROGNOSIS IN RENAL-CELL CARCINOMA
    DELAHUNT, B
    RIBAS, JL
    NACEY, JN
    BETHWAITE, PB
    [J]. JOURNAL OF PATHOLOGY, 1991, 163 (01) : 31 - 37
  • [5] RELATIONSHIP BETWEEN DNA PLOIDY AND SURVIVAL IN PATIENTS WITH EXOCRINE PANCREATIC-CANCER
    ESKELINEN, M
    LIPPONEN, P
    COLLAN, Y
    MARIN, S
    ALHAVA, E
    NORDLING, S
    [J]. PANCREAS, 1991, 6 (01) : 90 - 95
  • [6] THE ROLE OF NUCLEOLAR ORGANIZER REGIONS AS PROGNOSTIC FACTORS IN BREAST-CANCER
    ESKELINEN, MJ
    LIPPONEN, PK
    COLLAN, Y
    SYRJANEN, KJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 989 - 992
  • [7] SILVER-BINDING NUCLEOLAR ORGANIZER REGIONS (AGNORS) IN BENIGN AND MALIGNANT BREAST-LESIONS - CORRELATIONS WITH PLOIDY AND GROWTH-PHASE BY DNA FLOW-CYTOMETRY
    GIRI, DD
    NOTTINGHAM, JF
    LAWRY, J
    DUNDAS, SAC
    UNDERWOOD, JCE
    [J]. JOURNAL OF PATHOLOGY, 1989, 157 (04) : 307 - 313
  • [8] LEE E T, 1972, Computer Programs in Biomedicine, V2, P315, DOI 10.1016/0010-468X(72)90019-0
  • [9] LIPPONEN P, 1990, ANTICANCER RES, V10, P1725
  • [10] PROGRESSION AND SURVIVAL IN TRANSITIONAL CELL BLADDER-CANCER - A COMPARISON OF ESTABLISHED PROGNOSTIC FACTORS, S-PHASE FRACTION AND DNA PLOIDY
    LIPPONEN, PK
    ESKELINEN, MJ
    NORDLING, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) : 877 - 881